Results 31 to 40 of about 33,129 (159)

Baculovirus as an ideal radionuclide reporter gene vector: a new strategy for monitoring the fate of human stem cells in vivo.

open access: yesPLoS ONE, 2013
PurposeRadionuclide reporter gene imaging holds promise for non-invasive monitoring of transplanted stem cells. Thus, the feasibility of utilizing recombinant baculoviruses carrying the sodium iodide symporter (NIS) reporter gene in monitoring stem cell ...
Yu Pan   +5 more
doaj   +1 more source

Biomarkers in Prostate-Specific Membrane Antigen Theranostics

open access: yesDiagnostics, 2021
Theranostics of prostate cancer (PC) represents a growing area of development of imaging agents and targeted radionuclide therapeutics against a major target, prostate specific membrane antigen (PSMA).
Panagiotis J. Vlachostergios   +2 more
doaj   +1 more source

The application of radionuclide therapy for breast cancer

open access: yesFrontiers in Nuclear Medicine
Radionuclide-mediated diagnosis and therapy have emerged as effective and low-risk approaches to treating breast cancer. Compared to traditional anatomic imaging techniques, diagnostic radionuclide-based molecular imaging systems exhibit much greater ...
Anna Musket   +9 more
doaj   +1 more source

The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule

open access: yesScientific Reports, 2017
Several anti-cancer therapies target the epidermal growth factor receptor (EGFR). Radionuclide imaging of EGFR expression in tumours may aid in selection of optimal cancer therapy.
Javad Garousi   +10 more
doaj   +1 more source

Copper radionuclides for theranostic applications: towards standardisation of their nuclear data. A mini-review

open access: yesFrontiers in Chemistry, 2023
Copper has several clinically relevant radioisotopes and versatile coordination chemistry, allowing attachment of its radionuclides to biological molecules.
Mazhar Hussain   +5 more
doaj   +1 more source

Potential application of lutetium-177-labeled prostate-specific membrane antigen-617 radioligand therapy for metastatic castration-resistant prostate cancer in a limited resource environment: Initial clinical experience after 2 years

open access: yesWorld Journal of Nuclear Medicine, 2020
In recent years, lutetium-177 (177Lu)-labeled prostate-specific membrane antigen (PSMA)-617 has become a promising new therapeutic agent in patients with metastatic castration-resistant prostate cancer (mCRPC).
Majid Assadi   +9 more
doaj   +1 more source

Personalized Dosimetry for Radionuclide Therapy Using Molecular Imaging Tools

open access: yesBiomedicines, 2016
For treatment of systemic malignancies, when external radiation therapy is not applicable, radionuclide therapy can be an alternative. In this form of therapy, radionuclides are administered to the patient, often in a form where the radionuclide is ...
Michael Ljungberg   +1 more
doaj   +1 more source

Subcellular Targeting of Theranostic Radionuclides

open access: yesFrontiers in Pharmacology, 2018
The last decade has seen rapid growth in the use of theranostic radionuclides for the treatment and imaging of a wide range of cancers. Radionuclide therapy and imaging rely on a radiolabeled vector to specifically target cancer cells. Radionuclides that
Bas M. Bavelaar   +4 more
doaj   +1 more source

The Application of Radiolabeled Mesoporous Silica Nanoparticles in Molecular Imaging

open access: yesMolecules
In medicine, nanoparticles are used for various purposes, including theranostics, imaging, diagnostics, drug delivery, tissue regeneration and targeted cancer treatments, and to minimize the harmful side effects associated with conventional therapies ...
Aleksandra Lis   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy